Lifeist Provides Corporate Update
December 03, 2021 18:52 ET
|
Lifeist Wellness Inc.
TORONTO, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in...
PowerTap and Viridian Expo 2020 Tremendous Success
December 03, 2021 17:00 ET
|
PowerTap Hydrogen
VANCOUVER, British Columbia and IRVINE, Calif., Dec. 03, 2021 (GLOBE NEWSWIRE) -- PowerTap Hydrogen Capital Corp (NEO: MOVE) (FWB: 2K6B) (OTC: MOTNF) (“PowerTap” or the “Company” or “MOVE”) is...
TAAT™ Grows Northeastern U.S. Footprint with 350 Additional Stores in Virginia
December 03, 2021 16:01 ET
|
TAAT Global Alternatives Inc.
LAS VEGAS and VANCOUVER, British Columbia, Dec. 03, 2021 (GLOBE NEWSWIRE) -- TAAT™ GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT™”) is pleased to...
UPDATE -- Revive Therapeutics Expands Bucillamine Research to Treat Omicron Variant and Adds Inflammatory Markers to FDA Phase 3 Clinical Trial
December 03, 2021 09:31 ET
|
Revive Therapeutics Ltd.
Expanding the potential of Bucillamine as an effective treatment for Omicron variant (B.1.1.529)Bucillamine shown to inhibit SARS-CoV-2 infection in vitro for the Delta variant (B.1.617.2)Adding...
Giyani Closes Bought Deal Public Offering Raising Gross Proceeds of $11.5 Million
December 03, 2021 09:24 ET
|
Giyani Metals Corp.
Not for distribution to U.S. newswire services or for dissemination in the United States TORONTO, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Giyani Metals Corp. (TSXV:EMM, GR:A2DUU8) ("Giyani" or the...
Victory Square Technologies To Issue Second Tranche of Special Common Share Dividend of its Interest in Portfolio Company Fantasy 360 Technologies Inc. in December 2021
December 03, 2021 09:00 ET
|
Victory Square Technologies Inc.
Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, British Columbia, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc....
Revive Therapeutics Expands Bucillamine Research to Treat Omicron Variant and Adds Inflammatory Markers to FDA Phase 3 Clinical Trial
December 03, 2021 08:30 ET
|
Revive Therapeutics Ltd.
Expanding the potential of Bucillamine as an effective treatment for Omicron variant (B.1.1.529)Bucillamine shown to inhibit SARS-CoV-2 infection in vitro for the Delta variant (B.1.617.2)Adding...
H.C. Wainwright 2nd Annual Psychedelics Conference, BACK TO THE FUTURE!
December 03, 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Dec. 03, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Ecuador Constitutional Court Rules on exploration activities in the “Los Cedros” Protected Forest in the Rio Magdalena Project within the ENAMI EP Strategic Exploration Alliance in NW Ecuador
December 02, 2021 17:39 ET
|
Cornerstone Capital Resources Inc.
OTTAWA, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV:CGP) (Frankfurt:GWN) (Berlin:GWN) (OTC:CTNXF) announces that it was notified late...
KetamineOne Subsidiary KGK Science Helps Client Receive New Dietary Ingredient Status from U.S. FDA
December 02, 2021 17:00 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: MY0), a company focused on consolidating...